Immunopathology of inflammatory bowel disease

World Journal of Gastroenterology

Volumn 20, Issue 1, 2014, Pages 6-21

  Wallace, Kori L ^a   Zheng, Li Bo ^b   Kanazawa, Yoshitake ^a   Shih, David Q ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Adaptive immune system; Autophagy; Crohn's disease; Inflammatory bowel disease; Innate immune system; Innate lymphoid cells; Microbiome; T helper 17; TL1A; Ulcerative colitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; DEATH RECEPTOR 3; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 7; INTERLEUKIN 9; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; SECUKINUMAB; TOLL LIKE RECEPTOR;

ARTICLE; ASTHMA; AUTOPHAGY; BIFIDOBACTERIUM; CROHN DISEASE; DYSBIOSIS; ENCEPHALITIS; ENTERITIS; ESCHERICHIA COLI; FAECALIBACTERIUM; FECES ANALYSIS; GENE TRANSLOCATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; INFLAMMATORY BOWEL DISEASE; INTESTINE LYMPHATIC TISSUE; LYMPHOID CELL; NONHUMAN; PATHOGEN CLEARANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL; TH2 CELL; VIRUS INFECTION;

ADAPTIVE IMMUNE SYSTEM; AUTOPHAGY; CROHN'S DISEASE; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNE SYSTEM; INNATE LYMPHOID CELLS; MICROBIOME; T HELPER 17; TL1A; ULCERATIVE COLITIS;

ADAPTIVE IMMUNITY; ANIMALS; AUTOPHAGY; BACTERIA; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTESTINES; MICROBIOTA; RISK FACTORS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84891804080     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i1.6     Document Type: Article

References (162)

1. Lakatos PL. Recent trends in the epidemiology of infammatory bowel diseases: up or down? World J Gastroenterol 2006; 12: 6102-6108 [PMID: 17036379]
2. Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's disease in adults. Am J Gastroenterol 2009; 104: 465-83; quiz 464, 484 [PMID: 19174807 DOI: 10.1038/ ajg.2008.168]
3. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753 [PMID: 16698746 DOI: 10.1136/gut.2005.082909]
4. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997; 92: 204-211 [PMID: 9040192]
5. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005; 129: 827-836 [PMID: 16143122 DOI: 10.1053/ j.gastro.2005.06.021]
6. Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. Front Physiol 2012; 3: 13 [PMID: 22347192 DOI: 10.3389/fphys.2012.00013]
7. Bager P, Simonsen J, Nielsen NM, Frisch M. Cesarean section and offspring's risk of infammatory bowel disease: a national cohort study. Infamm Bowel Dis 2012; 18: 857-862 [PMID: 21739532 DOI: 10.1002/ibd.21805]
8. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poul-let JB, Massart S, Collini S, Pieraccini G, Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107: 14691-14696 [PMID: 20679230 DOI: 10.1073/pnas.1005963107]
9. Hviid A, Svanström H, Frisch M. Antibiotic use and infammatory bowel diseases in childhood. Gut 2011; 60: 49-54 [PMID: 20966024 DOI: 10.1136/gut.2010.219683]
10. Burton PR, Clayton DG, Cardon LR, Craddock N, De-loukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D, Easton D, Evans DM, Leung HT, Marchini JL, Morris AP, Spencer CC, Tobin MD, Attwood AP, Boor-man JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, Meech E, Nutland S, Prowse CV, Stevens HE, Taylor NC, Walters GR, Walker NM, Watkins NA, Winzer T, Jones RW, McArdle WL, Ring SM, Strachan DP, Pembrey M, Breen G, St Clair D, Caesar S, Gordon-Smith K, Jones L, Fraser C, Green EK, Grozeva D, Hamshere ML, Holmans PA, Jones IR, Kirov G, Moskivina V, Nikolov I, O'Donovan MC, Owen MJ, Collier DA, Elkin A, Farmer A, Williamson R, McGuffn P, Young AH, Ferrier IN, Ball SG, Balmforth AJ, Barrett JH, Bishop TD, Iles MM, Maqbool A, Yuldasheva N, Hall AS, Braund PS, Dixon RJ, Mangino M, Stevens S, Thompson JR, Bredin F, Tremelling M, Parkes M, Drum-mond H, Lees CW, Nimmo ER, Satsangi J, Fisher SA, Forbes A, Lewis CM, Onnie CM, Prescott NJ, Sanderson J, Matthew CG, Barbour J, Mohiuddin MK, Todhunter CE, Mansfield JC, Ahmad T, Cummings FR, Jewell DP, Webster J, Brown MJ, Lathrop MG, Connell J, Dominiczak A, Marcano CA, Burke B, Dobson R, Gungadoo J, Lee KL, Munroe PB, Newhouse SJ, Onipinla A, Wallace C, Xue M, Caulfeld M, Farrall M, Barton A, Bruce IN, Donovan H, Eyre S, Gilbert PD, Hilder SL, Hinks AM, John SL, Potter C, Silman AJ, Symmons DP, Thomson W, Worthington J, Dunger DB, Widmer B, Frayling TM, Freathy RM, Lango H, Perry JR, Shields BM, Weedon MN, Hattersley AT, Hitman GA, Walker M, Elliott KS, Groves CJ, Lindgren CM, Rayner NW, Timpson NJ, Zeggini E, Newport M, Sirugo G, Lyons E, Vannberg F, Hill AV, Bradbury LA, Farrar C, Pointon JJ, Wordsworth P, Brown MA, Franklyn JA, Heward JM, Simmonds MJ, Gough SC, Seal S, Stratton MR, Rahman N, Ban M, Goris A, Sawcer SJ, Compston A, Conway D, Jallow M, Newport M, Sirugo G, Rockett KA, Bumpstead SJ, Chaney A, Downes K, Ghori MJ, Gwilliam R, Hunt SE, Inouye M, Keniry A, King E, McGinnis R, Potter S, Ravindrarajah R, Whittaker P, Widden C, Withers D, Cardin NJ, Davison D, Ferreira T, PereiraGale J, Hallgrimsdo'ttir IB, Howie BN, Su Z, Teo YY, Vukcevic D, Bentley D, Brown MA, Compston A, Farrall M, Hall AS, Hattersley AT, Hill AV, Parkes M, Pembrey M, Stratton MR, Mitchell SL, Newby PR, Brand OJ, Carr-Smith J, Pearce SH, McGinnis R, Keniry A, Deloukas P, Reveille JD, Zhou X, Sims AM, Dowling A, Taylor J, Doan T, Davis JC, Savage L, Ward MM, Learch TL, Weisman MH, Brown M. Association scan of 14,500 nonsynonymous SNPs in four diseases identifes autoimmunity variants. Nat Genet 2007; 39: 1329-1337 [PMID: 17952073]
11. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kist-ner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463 [PMID: 17068223 DOI: 10.1126/science.1135245]
12. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, Anderson CA, Bis JC, Bumpstead S, Ellinghaus D, Festen EM, Georges M, Green T, Haritunians T, Jostins L, Latiano A, Mathew CG, Montgomery GW, Prescott NJ, Raychaudhuri S, Rotter JI, Schumm P, Sharma Y, Simms LA, Taylor KD, Whiteman D, Wijmenga C, Baldassano RN, Barclay M, Bay-less TM, Brand S, Büning C, Cohen A, Colombel JF, Cottone M, Stronati L, Denson T, De Vos M, D'Inca R, Dubinsky M, Edwards C, Florin T, Franchimont D, Gearry R, Glas J, Van Gossum A, Guthery SL, Halfvarson J, Verspaget HW, Hugot JP, Karban A, Laukens D, Lawrance I, Lemann M, Levine A, Libioulle C, Louis E, Mowat C, Newman W, Panés J, Phillips A, Proctor DD, Regueiro M, Russell R, Rutgeerts P, Sanderson J, Sans M, Seibold F, Steinhart AH, Stokkers PC, Torkvist L, Kullak-Ublick G, Wilson D, Walters T, Targan SR, Brant SR, Rioux JD, D'Amato M, Weersma RK, Kugath-asan S, Griffths AM, Mansfeld JC, Vermeire S, Duerr RH, Silverberg MS, Satsangi J, Schreiber S, Cho JH, Annese V, Hakonarson H, Daly MJ, Parkes M. Genome-wide metaanalysis increases to 71 the number of confrmed Crohn's disease susceptibility loci. Nat Genet 2010; 42: 1118-1125 [PMID: 21102463 DOI: 10.1038/ng.717]
13. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J, Giinther S, Prescott NJ, Onnie CM, Häsler R, Sipos B, Fölsch UR, Lengauer T, Platzer M, Mathew CG, Krawczak M, Schreiber S. A genome-wide association scan of nonsynonymous SNPs identifes a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39: 207-211 [PMID: 17200669 DOI: 10.1038/ngl954]
14. Bamias G, Corridoni D, Pizarro TT, Cominelli F. New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine 2012; 59: 451-459 [PMID: 22795953 DOI: 10.1016/j.cyto.2012.06.014]
15. Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand Immunol 2009; 70: 505-515 [PMID: 19906191 DOI: 10.1111/j.l365-3083.2009.02319.x]
16. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998; 114: 262-267 [PMID: 9453485]
17. Casellas F, Borruel N, Papo M, Guarner F, Antolín M, Vi-dela S, Malagelada JR. Antiinfammatory effects of enteri-cally coated amoxicillin-clavulanic acid in active ulcerative colitis. Infamm Bowel Dis 1998; 4: 1-5 [PMID: 9552221]
18. Strober W, Fuss I, Mannon P. The fundamental basis of infammatory bowel disease. Clin Invest 2007; 117: 514-521 [PMID: 17332878 DOI: 10.1172/JCI30587]
19. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007; 449: 804-810 [PMID: 17943116 DOI: 10.1038/ na-ture06244]
20. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638 [PMID: 15831718 DOI: 10.1126/science.1110591]
21. Caporaso JG, Lauber CL, Costello EK, Berg-Lyons D, Gonzalez A, Stombaugh J, Knights D, Gajer P, Ravel J, Fierer N, Gordon JI, Knight R. Moving pictures of the human microbiome. Genome Biol 2011; 12: R50 [PMID: 21624126 DOI: 10.1186/gb-2011-12-5-r50]
22. Qin J, Li R, Raes J, Arumugam M, Burgdorf KB, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD, Wang J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65 [PMID: 20203603 DOI: 10.1038/ nature08821]
23. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Doré J, Antolín M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Hairnet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le Roux K, Maguin E, Mérieux A, Melo Minardi R, M'rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-180 [PMID: 21508958 DOI: 10.1038/nature09944]
24. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104: 13780-13785 [PMID: 17699621 DOI: 10.1073/ pnas.0706625104]
25. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN, Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microfora in patients with active infammatory bowel disease. Gut 2004; 53: 685-693 [PMID: 15082587]
26. Lepage P, Häsler R, Spehlmann ME, Rehman A, Zvirbliene A, Begun A, Ott S, Kupcinskas L, Doré J, Raedler A, Sch-reiber S. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 2011; 141: 227-236 [PMID: 21621540 DOI: 10.1053/j.gastro.2011.04.011]
27. Chassaing B, Darfeuille-Michaud A. The commensal micro-biota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1720-1728 [PMID: 21530738 DOI: 10.1053/j.gastro.2011.01.054]
28. Sokol H, Lepage P, Seksik P, Doré J, Marteau P. Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol 2006; 44: 3172-3177 [PMID: 16954244 DOI: 10.1128/JCM.02600-05]
29. Kang S, Denman SE, Morrison M, Yu Z, Dore J, Leclerc M, McSweeney CS. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microar-ray. Infamm Bowel Dis 2010; 16: 2034-2042 [PMID: 20848492 DOI: 10.1002/ibd.21319]
30. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pel-letier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55: 205-211 [PMID: 16188921 DOI: 10.1136/ gut.2005.073817]
31. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Järnerot G, Tysk C, Jansson JK, Engstrand L. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139: 1844-1854.e1 [PMID: 20816835 DOI: 10.1053/j.gastro.2010.08.049]
32. Martinez-Medina M, Aldeguer X, Lopez-Siles M, González-Huix F, López-Oliu C, Dahbi G, Blanco JE, Blanco J, Garcia-Gil LJ, Darfeuille-Michaud A. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Infamm Bowel Dis 2009; 15: 872-882 [PMID: 19235912 DOI: 10.1002/ibd.20860]
33. Darfeuille-Michaud A. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn' s disease. Int J Med Microbiol 2002; 292: 185-193 [PMID: 12398209 DOI: 10.1078/1438-4221-00201]
34. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glass-er AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF. High prevalence of adherent-invasive Esch-erichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412-421 [PMID: 15300573]
35. Barnich N, Boudeau J, Claret L, Darfeuille-Michaud A. Regulatory and functional co-operation of fagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease. Mol Microbiol 2003; 48: 781-794 [PMID: 12694621]
36. Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M, Peeters H, Bommelaer G, Desreumaux P, Colom-bel JF, Darfeuille-Michaud A. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007; 117: 1566-1574 [PMID: 17525800 DOI: 10.1172/JCI30504]
37. Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, Stanners CP, Darfeuille-Michaud A. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 2009; 206: 2179-2189 [PMID: 19737864 DOI: 10.1084/jem.20090741]
38. Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colom-bel JF, Darfeuille-Michaud A. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun 2001; 69: 5529-5537 [PMID: 11500426]
39. Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010; 12: 99-113 [PMID: 19747213 DOI: 10.1111/j.l462-5822.2009.01381.x]
40. Goodridge HS, Reyes CN, Becker CA, Katsumoto TR, Ma J, Wolf AJ, Bose N, Chan AS, Magee AS, Danielson ME, Weiss A, Vasilakos JP, Underhill DM. Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'. Nature 2011; 472: 471-475 [PMID: 21525931 DOI: 10.1038/naturel 0071]
41. Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M, Rotter JI, Wang HL, McGovern DP, Brown GD, Underhill DM. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 infuence colitis. Science 2012; 336: 1314-1317 [PMID: 22674328 DOI: 10.1126/science.1221789]
42. Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, Storer CE, Head RD, Xavier R, Stappenbeck TS, Virgin HW. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atgl6Ll phenotypes in intestine. Cell 2010; 141: 1135-1145 [PMID: 20602997 DOI: 10.1016/j.cell.2010.05.009]
43. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12: 1365-1371 [PMID: 17115046 DOI: 10.1038/nml511]
44. Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol 2012; 30: 149-173 [PMID: 22224779 DOI: 10.1146/annurev-immunol-020711-075001]
45. Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, Paiardini M, Barclay GR, Smedley J, Pung R, Oliveira KM, Hirsch VM, Silvestri G, Douek DC, Miller CJ, Haase AT, Lifson J, Brenchley JM. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010; 6: el001052 [PMID: 20808901 DOI: 10.1371/journal.ppat.l001052]
46. Handley SA, Thackray LB, Zhao G, Presti R, Miller AD, Droit L, Abbink P, Maxfeld LF, Kambal A, Duan E, Stanley K, Kramer J, Macri SC, Permar SR, Schmitz JE, Mansfield K, Brenchley JM, Veazey RS, Stappenbeck TS, Wang D, Barouch DH, Virgin HW. Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome. Cell 2012; 151: 253-266 [PMID: 23063120 DOI: 10.1016/j.cell.2012.09.024]
47. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010; 464: 1371-1375 [PMID: 20393462 DOI: 10.1038/nature08949]
48. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodefcient mice. Gastroen-terology 1994; 107: 1643-1652 [PMID: 7958674]
49. Maloy KJ, Powrie F. Intestinal homeostasis and its break-down in inflammatory bowel disease. Nature 2011; 474: 298-306 [PMID: 21677746 DOI: 10.1038/nature10208]
50. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005; 206: 260-276 [PMID: 16048554 DOI: 10.1111/ j.0105-2896.2005.00291.x]
51. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Büller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AW. Muc2-defcient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006; 131: 117-129 [PMID: 16831596 DOI: 10.1053/j.gastro.2006.04.020]
52. Larsson JM, Karlsson H, Crespo JG, Johansson ME, Eklund L, Sjövall H, Hansson GC. Altered O-glycosylation profle of MUC2 mucin occurs in active ulcerative colitis and is associated with increased infammation. Infamm Bowel Dis 2011; 17: 2299-2307 [PMID: 21290483 DOI: 10.1002/ibd.21625]
53. Blackwell CC, Jonsdottir K, Hanson MF, Weir DM. Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet 1986; 2: 687 [PMID: 2876155]
54. Blackwell CC, Jónsdóttir K, Hanson M, Todd WT, Chaud-huri AK, Mathew B, Brettle RP, Weir DM. Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet 1986; 2: 284-285 [PMID: 2874307]
55. Carlsson B, Kindberg E, Buesa J, Rydell GE, Lidón MF, Montava R, Abu Mallouh R, Grahn A, Rodríguez-Díaz J, Bellido J, Arnedo A, Larson G, Svensson L. The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection. PLoS One 2009; 4: e5593 [PMID: 19440360 DOI: 10.1371/ journal.pone.0005593]
56. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. Sequence and expression of a candidate for the human Secre-tor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 1995; 270: 4640-4649 [PMID: 7876235]
57. Marionneau S, Airaud F, Bovin NV, Le Pendu J, Ruvoën-Clouet N. Infuence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J Infect Dis 2005; 192: 1071-1077 [PMID: 16107962 DOI: 10.1086/432546]
58. McGovern DP, Gardet A, Törkvist L, Goyette P, Essers J, Taylor KD, Neale BM, Ong RT, Lagacé C, Li C, Green T, Stevens CR, Beauchamp C, Fleshner PR, Carlson M, D'Amato M, Halfvarson J, Hibberd ML, Lördal M, Padyukov L, Andriulli A, Colombo E, Latiano A, Palmieri O, Bernard EJ, Deslandres C, Hommes DW, de Jong DJ, Stokkers PC, Weersma RK, Sharma Y, Silverberg MS, Cho JH, Wu J, Ro-eder K, Brant SR, Schumm LP, Duerr RH, Dubinsky MC, Glazer NL, Haritunians T, Ippoliti A, Melmed GY, Siscovick DS, Vasiliauskas EA, Targan SR, Annese V, Wijmenga C, Pettersson S, Rotter JI, Xavier RJ, Daly MJ, Rioux JD, Seiel-stad M. Genome-wide association identifes multiple ulcer-ative colitis susceptibility loci. Nat Genet 2010; 42: 332-337 [PMID: 20228799 DOI: 10.1038/ng.549]
59. Thorven M, Grahn A, Hedlund KO, Johansson H, Wahlfrid C, Larson G, Svensson L. A homozygous nonsense mutation (428G--& gt; A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol 2005; 79: 15351-15355 [PMID: 16306606 DOI: 10.1128/ JVI.79.24.15351-15355.2005]
60. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, Newman B, Van Oene M, Cescon D, Greenberg G, Griffths AM, St George-Hyslop PH, Siminovitch KA. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004; 36: 471-475 [PMID: 15107849 DOI: 10.1038/ngl339]
61. Roediger WE, Nance S. Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br Exp Pathol 1986; 67: 773-782 [PMID: 3099821]
62. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241 [PMID: 15260992 DOI: 10.1016/ j.cell.2004.07.002]
63. Berkes J, Viswanathan VK, Savkovic SD, Hecht G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and infammation. Gut 2003; 52: 439-451 [PMID: 12584232]
64. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292: 1115-1118 [PMID: 11352068]
65. Madara JL, Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. Clin Invest 1989; 83: 724-727 [PMID: 2492310 DOI: 10.1172/ JCI113938]
66. Taylor CT, Dzus AL, Colgan SP. Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. Gastroenterology 1998; 114: 657-668 [PMID: 9516386]
67. Saruta M, Targan SR, Mei L, Ippoliti AF, Taylor KD, Rotter JI. High-frequency haplotypes in the X chromosome locus TLR8 are associated with both CD and UC in females. Infamm Bowel Dis 2009; 15: 321-327 [PMID: 18942751 DOI: 10.1002/ibd.20754]
68. Ghosh TK, Mickelson DJ, Fink J, Solberg JC, Inglefeld JR, Hook D, Gupta SK, Gibson S, Alkan SS. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses. Cell Immunol 2006; 243: 48-57 [PMID: 17250816 DOI: 10.1016/ j.cellimm.2006.12.002]
69. Török HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C. Crohn's disease is associated with a tolllike receptor-9 polymorphism. Gastroenterology 2004; 127: 365-366 [PMID: 15236225]
70. O'Hara JR, Feener TD, Fischer CD, Buret AG. Campylo-bacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice. Infect Immun 2012; 80: 1563-1571 [PMID: 22311925 DOI: 10.1128/ IAI.06066-11]
71. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 390-407 [PMID: 16819502 DOI: 10.1038/ncp-gasthep0528]
72. Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MA, Geuking MB, Beutler B, Tedder TF, Hardt WD, Bercik P, Verdu EF, McCoy KD, Macpherson AJ. Innate and adaptive immunity cooperate fexibly to maintain host-microbiota mutualism. Science 2009; 325: 617-620 [PMID: 19644121 DOI: 10.1126/science.1172747]
73. Hermiston ML, Gordon JI. Infammatory bowel disease and adenomas in mice expressing a dominant negative N-cad-herin. Science 1995; 270: 1203-1207 [PMID: 7502046]
74. Natividad JM, Petit V, Huang X, de Palma G, Jury J, Sanz Y, Philpott D, Garcia Rodenas CL, McCoy KD, Verdu EF. Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nodi-/-; Nod2-/mice. Infamm Bowel Dis 2012; 18: 1434-1446 [PMID: 22162005 DOI: 10.1002/ibd.22848]
75. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Aimer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603 [PMID: 11385576 DOI: 10.1038/35079107]
76. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and infammation. Nature 2011; 469: 323-335 [PMID: 21248839 DOI: 10.1038/nature09782]
77. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, Kishi C, Kc W, Carrero JA, Hunt S, Stone CD, Brunt EM, Xavier RJ, Sleckman BP, Li E, Mizushima N, Stappenbeck TS, Virgin HW. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008; 456: 259-263 [PMID: 18849966 DOI: 10.1038/na-ture07416]
78. Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, Ferguson DJ, Campbell BJ, Jewell D, Simmons A. NOD2 stimulation induces autophagy in dendritic cells infuencing bacterial handling and antigen presentation. Nat Med 2010; 16: 90-97 [PMID: 19966812 DOI: 10.1038/nm.2069]
79. Singh SB, Davis AS, Taylor GA, Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006; 313: 1438-1441 [PMID: 16888103 DOI: 10.1126/ science.1129577]
80. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, Shugart YY, Griffths AM, Targan SR, Ippoliti AF, Bernard EJ, Mei L, Nicolae DL, Regueiro M, Schumm LP, Steinhart AH, Rotter JI, Duerr RH, Cho JH, Daly MJ, Brant SR. Genome-wide association study identifes new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007; 39: 596-604 [PMID: 17435756 DOI: 10.1038/ng2032]
81. Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 2012; 30: 647-675 [PMID: 22224763 DOI: 10.1146/annurev-immunol-020711-075053]
82. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, Powrie F, Vivier E. Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13: 145-149 [PMID: 23348417 DOI: 10.1038/nri3365]
83. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R, Muchamuel T, Hurst SD, Zurawski G, Leach MW, Gorman DM, Rennick DM. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001; 15: 985-995 [PMID: 11754819]
84. Hurst SD, Muchamuel T, Gorman DM, Gilbert JM, Clifford T, Kwan S, Menon S, Seymour B, Jackson C, Kung TT, Bri-eland JK, Zurawski SM, Chapman RW, Zurawski G, Coff-man RL. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002; 169: 443-453 [PMID: 12077275]
85. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R, Jolin HE, McKenzie AN. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464: 1367-1370 [PMID: 20200518 DOI: 10.1038/nature08900]
86. Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 2010; 107: 11489-11494 [PMID: 20534524 DOI: 10.1073/ pnas.1003988107]
87. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, Dekruyff RH, Umetsu DT. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011; 12: 631-638 [PMID: 21623379 DOI: 10.1038/ni.2045]
88. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, Kubota M, Turner D, Diamond JM, Goldrath AW, Farber DL, Collman RG, Wherry EJ, Artis D. Innate lymphoid cells promote lung-tissue homeostasis after infection with infuenza virus. Nat Immunol 2011; 12: 1045-1054 [PMID: 21946417 DOI: 10.1031/ni.2131]
89. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Iva-nov II, Littman DR, O'Shea JJ. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. Exp Med 2009; 206: 35-41 [PMID: 19114665 DOI: 10.1084/jem.20072713]
90. Eken A, Singh AK, Treuting PM, Oukka M. IL-23R(+) innate lymphoid cells induce colitis via interleukin-22-depen-dent mechanism. Mucosal Immunol 2014; 7: 143-154 [PMID: 23715173 DOI: 10.1038/mi.2013.33]
91. Geremia A, Arancibia-Cárcamo CV, Fleming MP, Rust N, Singh B, Mortensen NJ, Travis SP, Powrie F. IL-23-responsive innate lymphoid cells are increased in infammatory bowel disease. Exp Med 2011; 208: 1127-1133 [PMID: 21576383 DOI: 10.1084/jem.20101712]
92. Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, Flach M, Bengsch B, Thimme R, Hölscher C, Hönig M, Pannicke U, Schwarz K, Ware CF, Finke D, Diefenbach A. Regulated expression of nuclear receptor RORyt confers distinct functional fates to NK cell receptor-expressing RORyt(+) innate lymphocytes. Immunity 2010; 33: 736-751 [PMID: 21093318 DOI: 10.1016/ j.immuni.2010.10.017]
93. Chinen H, Matsuoka K, Sato T, Kamada N, Okamoto S, Hisamatsu T, Kobayashi T, Hasegawa H, Sugita A, Kinjo F, Fujita J, Hibi T. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells. Gastroenterology 2007; 133: 559-573 [PMID: 17681176 DOI: 10.1053/j.gastro.2007.05.017]
94. Takayama T, Kamada N, Chinen H, Okamoto S, Kita-zume MT, Chang J, Matuzaki Y, Suzuki S, Sugita A, Koganei K, Hisamatsu T, Kanai T, Hibi T. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. Gastroenterology 2010; 139: 882-892, 892.el-3 [PMID: 20638936 DOI: 10.1053/j.gastro.2010.05.040]
95. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 227-257 [PMID: 8011282 DOI: 10.1146/annurev.iy.12.040194.001303]
96. Shih DQ, Targan SR, McGovern D. Recent advances in IBD pathogenesis: genetics and immunobiology. Curr Gastroen-terol Rep 2008; 10: 568-575 [PMID: 19006613]
97. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, Mac-Donald TT. Interleukin-2and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993; 78: 127-131 [PMID: 8436398]
98. Noguchi M, Hiwatashi N, Liu Z, Toyota T. Enhanced inter-feron-gamma production and B7-2 expression in isolated intestinal mononuclear cells from patients with Crohn's disease. Gastroenterol 1995; 30 Suppl 8: 52-55 [PMID: 8563891]
99. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. Disparate CD4+ lamina propria (LP) lymphokine secretion profles in infammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. Immunol 1996; 157: 1261-1270 [PMID: 8757634]
100. Fuss IJ, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S, Yang Z, Exley M, Kitani A, Blumberg RS, Mannon P, Strober W. Nonclassical CDld-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. Clin Invest 2004; 113: 1490-1497 [PMID: 15146247 DOI: 10.1172/JCI19836]
101. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Biirgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005; 129: 550-564 [PMID: 16083712 DOI: 10.1016/ j.gastro.2005.05.002]
102. Rovedatti L, Kudo T, Biancheri P, Sarra M, Knowles CH, Rampton DS, Corazza GR, Monteleone G, Di Sabatino A, Macdonald TT. Differential regulation of interleukin 17 and interferon gamma production in infammatory bowel disease. Gut 2009; 58: 1629-1636 [PMID: 19740775 DOI: 10.1136/gut.2009.182170]
103. Vainer B, Nielsen OH, Hendel J, Horn T, Kirman I. Colonic expression and synthesis of interleukin 13 and interleu-kin 15 in inflammatory bowel disease. Cytokine 2000; 12: 1531-1536 [PMID: 11023669 DOI: 10.1006/cyto.2000.0744]
104. Sakuraba A, Sato T, Kamada N, Kitazume M, Sugita A, Hibi T. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenter-ology 2009; 137: 1736-1745 [PMID: 19632232 DOI: 10.1053/ j.gastro.2009.07.049]
105. Dong C, Nurieva RI. Regulation of immune and autoimmune responses by ICOS. J Autoimmun 2003; 21: 255-260 [PMID: 14599850]
106. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8: 337-348 [PMID: 18408735 DOI: 10.1038/ nri2295]
107. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8: 967-974 [PMID: 17581537 DOI: 10.1038/ni1488]
108. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. The orphan nuclear receptor RORgammat directs the differentiation program of proin-fammatory IL-17+ T helper cells. Cell 2006; 126: 1121-1133 [PMID: 16990136 DOI: 10.1016/j.cell.2006.07.035]
109. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, Ma L, Shah B, Panopoulos AD, Schluns KS, Wa-towich SS, Tian Q, Jetten AM, Dong C. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008; 28: 29-39 [PMID: 18164222 DOI: 10.1016/j.immuni.2007.11.016]
110. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821-852 [PMID: 17201677 DOI: 10.1146/annurev.immunol.25.022106.141557]
111. Khalturin K, Panzer Z, Cooper MD, Bosch TC. Recognition strategies in the innate immune system of ancestral chor-dates. Mol Immunol 2004; 41: 1077-1087 [PMID: 15476919 DOI: 10.1016/j.molimm.2004.06.010]
112. Shalom-Barak T, Quach J, Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem 1998; 273: 27467-27473 [PMID: 9765276]
113. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI, Spriggs MK. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cyto-kine receptor. Immunity 1995; 3: 811-821 [PMID: 8777726]
114. Awane M, Andres PG, Li DJ, Reinecker HC. NF-kappa B-in-ducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol 1999; 162: 5337-5344 [PMID: 10228009]
115. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S. T cell interleukin-17 induces stromal cells to produce proinfammatory and he-matopoietic cytokines. J Exp Med 1996; 183: 2593-2603 [PMID: 8676080]
116. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F, Pelletier JP. IL-17 stimulates the production and expression of proinflammatory cyto-kines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998; 160: 3513-3521 [PMID: 9531313]
117. Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, Wisniewska J, Polubinska A, Friess H, Gahl GM, Frei U, Jörres A. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 2000; 165: 5814-5821 [PMID: 11067941]
118. Ahern PP, Schiering C, Buonocore S, McGeachy MJ, Cua DJ, Maloy KJ, Powrie F. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 2010; 33: 279-288 [PMID: 20732640 DOI: 10.1016/ j.immuni.2010.08.010]
119. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Fill L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, Romag-nani S. Phenotypic and functional features of human Thl7 cells. J Exp Med 2007; 204: 1849-1861 [PMID: 17635957 DOI: 10.1084/jem.20070663]
120. Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, Rodolico G, Querci V, Abbate G, Angeli R, Berrino L, Fambrini M, Caproni M, Tonelli F, Lazzeri E, Parronchi P, Liotta F, Maggi E, Romagnani S, Annunziato F. Human in-terleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 2008; 205: 1903-1916 [PMID: 18663128 DOI: 10.1084/jem.20080397]
121. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132 [PMID: 16200070 DOI: 10.1038/nil254]
122. Sujino T, Kanai T, Ono Y, Mikami Y, Hayashi A, Doi T, Matsuoka K, Hisamatsu T, Takaishi H, Ogata H, Yo-shimura A, Littman DR, Hibi T. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells. Gastroenterol-ogy 2011; 141: 1014-1023 [PMID: 21699791 DOI: 10.1053/ j.gastro.2011.05.052]
123. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y. Increased expression of interleukin 17 in infammatory bowel disease. Gut 2003; 52: 65-70 [PMID: 12477762]
124. Kolls JK, Lindén A. Interleukin-17 family members and infammation. Immunity 2004; 21: 467-476 [PMID: 15485625 DOI: 10.1016/j.immuni.2004.08.018]
125. Sugihara T, Kobori A, Imaeda H, Tsujikawa T, Amagase K, Takeuchi K, Fujiyama Y, Andoh A. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease. Clin Exp Immunol 2010; 160: 386-393 [PMID: 20089077 DOI: 10.1111/ j.l365-2249.2010.04093.x]
126. Dambacher J, Beigel F, Zitzmann K, De Toni EN, Göke B, Diepolder HM, Auernhammer CJ, Brand S. The role of the novel Thl7 cytokine IL-26 in intestinal inflammation. Gut 2009; 58: 1207-1217 [PMID: 18483078 DOI: 10.1136/ gut.2007.130112]
127. Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, Ramos HL, Wei L, Davidson TS, Bouladoux N, Grainger JR, Chen Q, Kanno Y, Watford WT, Sun HW, Eberl G, Shevach EM, Belkaid Y, Cua DJ, Chen W, O'Shea JJ. Generation of pathogenic T(H)17 cells in the absence of TGF-p signalling. Nature 2010; 467: 967-971 [PMID: 20962846 DOI: 10.1038/nature09447]
128. Bush KA, Farmer KM, Walker JS, Kirkham BW. Reduction of joint infammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgGl Fc fusion protein. Arthritis Rheum 2002; 46: 802-805 [PMID: 11920418 DOI: 10.1002/art.10173]
129. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006; 177: 566-573 [PMID: 16785554]
130. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Infamm Bowel Dis 2006; 12: 382-388 [PMID: 16670527 DOI: 10.1097/01.MIB.0000218764.06959.91]
131. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Inter-leukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14: 155-174 [PMID: 12651226]
132. O'Connor W, Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y, Kolls JK, Flavell RA. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009; 10: 603-609 [PMID: 19448631 DOI: 10.1038/ni.1736]
133. Sarra M, Pallone F, Macdonald TT, Monteleone G. IL-23/ IL-17 axis in IBD. Inflamm Bowel Dis 2010; 16: 1808-1813 [PMID: 20222127 DOI: 10.1002/ibd.21248]
134. Awasthi A, Kuchroo VK. IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation. Nat Immunol 2009; 10: 568-570 [PMID: 19448657 DOI: 10.1038/ni0609-568]
135. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 2004; 110: 55-62 [PMID: 14962796 DOI: 10.1016/j.clim.2003.09.013]
136. Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, Wehkamp J, Feagan BG, Yao MD, Karczewski M, Karczewski J, Pezous N, Bek S, Bruin G, Mellgard B, Berger C, Londei M, Bertolino AP, Tougas G, Travis SP. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012; 61: 1693-1700 [PMID: 22595313 DOI: 10.1136/gutjnl-2011-301668]
137. Cassatella MA, Pereira-da-Silva G, Tinazzi I, Facchetti F, Scapini P, Calzetti F, Tamassia N, Wei P, Nardelli B, Roschke V, Vecchi A, Mantovani A, Bambara LM, Edwards SW, Carletto A. Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J Immunol 2007; 178: 7325-7333 [PMID: 17513783]
138. Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, Cho YH, Ullrich S, Kana-karaj P, Carrell J, Boyd E, Olsen HS, Hu G, Pukac L, Liu D, Ni J, Kim S, Gentz R, Feng P, Moore PA, Ruben SM, Wei P. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002; 16: 479-492 [PMID: 11911831]
139. Prehn JL, Thomas LS, Landers CJ, Yu QT, Michelsen KS, Targan SR. The T cell costimulator TL1A is induced by Fc-gammaR signaling in human monocytes and dendritic cells. J Immunol 2007; 178: 4033-4038 [PMID: 17371957]
140. Shih DQ, Kwan LY, Chavez V, Cohavy O, Gonsky R, Chang EY, Chang C, Elson CO, Targan SR. Microbial induction of infammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur J Immunol 2009; 39: 3239-3250 [PMID: 19839006 DOI: 10.1002/eji.200839087]
141. Screaton GR, Xu XN, Olsen AL, Cowper AE, Tan R, Mc-Michael AJ, Bell JI. LARD: a new lymphoid-specifc death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci USA 1997; 94: 4615-4619 [PMID: 9114039]
142. Barrett R, Zhang X, Koon HW, Vu M, Chang JY, Yeager N, Nguyen MA, Michelsen KS, Berel D, Pothoulakis C, Targan SR, Shih DQ. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal infammation and induces fbrostenosis. Am J Pathol 2012; 180: 636-649 [PMID: 22138299 DOI: 10.1016/ j.ajpath.2011.10.026]
143. Shih DQ, Barrett R, Zhang X, Yeager N, Koon HW, Phao-sawasdi P, Song Y, Ko B, Wong MH, Michelsen KS, Martins G, Pothoulakis C, Targan SR. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal infammation and fbrosis. PLoS One 2011; 6: e16090 [PMID: 21264313 DOI: 10.1371/journal.pone.0016090]
144. Zheng L, Zhang X, Chen J, Ichikawa R, Wallace K, Pothou-lakis C, Koon HW, Targan SR, Shih DQ. Sustained tl1a (TNFSF15) expression on both lymphoid and myeloid cells leads to mild spontaneous intestinal inflammation and fi-brosis. Eur J Microbiol Immunol (Bp) 2013; 3: 11-20 [PMID: 23638306 DOI: 10.1556/EuJMI.3.2013.1.2]
145. Meylan F, Richard AC, Siegel RM. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte co-stimulation, mucosal hyperplasia, and autoimmune infam-mation. Immunol Rev 2011; 244: 188-196 [PMID: 22017439 DOI: 10.1111/j.1600-065X.2011.01068.x]
146. Meylan F, Song YJ, Fuss I, Villarreal S, Kahle E, Malm IJ, Acharya K, Ramos HL, Lo L, Mentink-Kane MM, Wynn TA, Migone TS, Strober W, Siegel RM. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal infammation. Mucosal Immunol 2011; 4: 172-185 [PMID: 20980995 DOI: 10.1038/mi.2010.67]
147. Taraban VY, Slebioda TJ, Willoughby JE, Buchan SL, James S, Sheth B, Smyth NR, Thomas GJ, Wang EC, Al-Shamkhani A. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol 2011; 4: 186-196 [PMID: 20962771 DOI: 10.1038/mi.2010.70]
148. Yamazaki K, McGovern D, Ragoussis J, Paolucci M, Butler H, Jewell D, Cardon L, Takazoe M, Tanaka T, Ichimori T, Saito S, Sekine A, Iida A, Takahashi A, Tsunoda T, Lathrop M, Nakamura Y. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005; 14: 3499-3506 [PMID: 16221758 DOI: 10.1093/hmg/ ddi379]
149. Kakuta Y, Kinouchi Y, Negoro K, Takahashi S, Shimosega-wa T. Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease. Gut 2006; 55: 1527-1528 [PMID: 16966713 DOI: 10.1136/ gut.2006.100297]
150. Picornell Y, Mei L, Taylor K, Yang H, Targan SR, Rotter JI. TNFSF15 is an ethnic-specific IBD gene. Inflamm Bowel Dis 2007; 13: 1333-1338 [PMID: 17663424 DOI: 10.1002/ ibd.20223]
151. Thiébaut R, Kotti S, Jung C, Merlin F, Colombel JF, Lemann M, Almer S, Tysk C, O'Morain M, Gassull M, Binder V, Finkel Y, Pascoe L, Hugot JP. TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort. Am J Gastroenterol 2009; 104: 384-391 [PMID: 19174806 DOI: 10.1038/ajg.2008.36]
152. Tremelling M, Berzuini C, Massey D, Bredin F, Price C, Dawson C, Bingham SA, Parkes M. Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population. Inflamm Bowel Dis 2008; 14: 733-737 [PMID: 18338776 DOI: 10.1002/ibd.20399]
153. Yang SK, Lim J, Chang HS, Lee I, Li Y, Liu J, Song K. Association of TNFSF15 with Crohn's disease in Koreans. Am J Gastroenterol 2008; 103: 1437-1442 [PMID: 18422820 DOI: 10.1111/j.1572-0241.2007.01752.x]
154. Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 2004; 99: 2376-2384 [PMID: 15571586 DOI: 10.1111/j.1572-0241.2004.40417.x]
155. Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papada-kis KA, Taylor KD, Landers CJ, Abreu-Martin MT, Rotter JI, Yang H, Targan SR. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004; 126: 414-424 [PMID: 14762777]
156. Michelsen KS, Thomas LS, Taylor KD, Yu QT, Mei L, Landers CJ, Derkowski C, McGovern DP, Rotter JI, Targan SR. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS One 2009; 4: e4719 [PMID: 19262684 DOI: 10.1371/journal.pone.0004719]
157. Takedatsu H, Michelsen KS, Wei B, Landers CJ, Thomas LS, Dhall D, Braun J, Targan SR. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 2008; 135: 552-567 [PMID: 18598698 DOI: 10.1053/j.gastro.2008.04.037]
158. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, Khoury S, Oukka M, Kuchroo VK. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008; 9: 1347-1355 [PMID: 18997793 DOI: 10.1038/ni.1677]
159. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pal-lotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann C, Beh-rendt H, Durham SR, Schmidt-Weber CB, Cavani A. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009; 119: 3573-3585 [PMID: 19920355 DOI: 10.1172/JCI40202]
160. King C, Sprent J. Emerging cellular networks for regulation of T follicular helper cells. Trends Immunol 2012; 33: 59-65 [PMID: 22209178 DOI: 10.1016/j.it.2011.11.006]
161. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-562 [PMID: 15032588 DOI: 10.1146/annurev.immunol.21.120601.141122]
162. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009; 30: 646-655 [PMID: 19464987 DOI: 10.1016/j.immuni.2009.05.001]